Policy Briefings

TAPI Appoints Serge Rogasik as Chief Executive Officer

ALK Expands Catalent Partnership to Secure Long-Term Allergy Tablet Supply

OnDosis and Adare Pharma Solutions Launch U.S. ADHD Drug-Device Collaboration

Ensera Launches Alliance Network for Drug-Device Combination Products

Merck Opens €70M Expansion at St. Louis ADC Manufacturing Center

NorthStar Medical Technologies Secures Up to $185M Growth Capital Facility

Piramal Pharma Solutions Receives $1.75M Ontario Investment for Aurora Site

Minaris Adds Viral Vectors Business Unit to Expand CGT Model

Genezen Partners on AAV9 Gene Therapy for Ultra-Rare ARCA2 Disorder

ESTEVE CDMO Expands Morton Grove Facility With $33M Total Investment

Forge Biologics Partners With TECPR2 Research Foundation on AAV Gene Therapy

Axplora Completes First R&D Batches of Exatecan for ADC Developers

Serán Bioscience Announces Growth Investment to Expand Commercial Manufacturing

Quotient Sciences and Acesion Pharma Launch AI Formulation Collaboration

CARBOGEN AMCIS Completes First FDA Pre-Approval Inspection at Vionnaz

Biodextris Appoints Clement Fourny as Chief Executive Officer

Lifecore Biomedical Agrees to $663.7M Acquisition by Webster Equity Partners

4basebio Partners With TriLink on Cell Therapy Manufacturing Program